Eric Halioua
(MS, MBA), Chief Executive Officer
President of the Board
e.halioua@pdc-line-pharma.com

http://www.pdc-line-pharma.com
CHU - Tour 5 (B34) – GIGA, Avenue de l'Hôpital 11
4000 LIEGE
Belgium

Eric is a serial entrepreneur that combines strong strategic, technological, managerial, fund-raising and deal-making experience. During his career he achieved together with his different teams to bring four drug candidates from research to the clinics (up to phase IIb). Overall, he has raised as of now a total of more than €130 million from VCs and strategic partners in Europe, USA, Japan and Korea and have had numerous successes in the sale and initial public offering of biotechnology companies. Eric is co-founder of four biotechnology called Myosix (bought by Genzyme mid-2002), Murigenetics, Digital Orthopaedics and HairClone. Eric worked for 12 years as a Principal in the Healthcare and Life Sciences Practice of Arthur D. Little.  Eric holds two master degrees in Pharmacology and Molecular Biology and a MBA from ESSEC business school (Paris). Eric is as well Board member of Digital Orthopaedics (Belgium) and the biotechnology company VitriCell (Belgium).